Option Care Health competitors, on the record
The companies Option Care Health names as competitors in its annual reports, 2023 to 2025, and the companies that name Option Care Health, each with the sentence and the filing.
Who Option Care Health names
| Company | Named in |
|---|---|
| Accredo | 2025 |
| Amerita Specialty Pharmacy (a division of BrightSpring Health) | 2025 |
| Coram CVS/specialty infusion services (a division of CVS Health) | 2025 |
| CVS Caremark | 2025 |
| KabaFusion | 2025 |
| Optum Infusion Pharmacy (a unit of UnitedHealth Group) | 2025 |
| Optum Rx | 2025 |
| Orsini | 2025 |
| Soleo Health | 2025 |
| Vital Care | 2025 |
In its own words
Accredo, Amerita Specialty Pharmacy (a division of BrightSpring Health), Coram CVS/specialty infusion services (a division of CVS Health), CVS Caremark, KabaFusion, Optum Infusion Pharmacy (a unit of UnitedHealth Group), Optum Rx, Orsini, Soleo Health, Vital Care
Word for word“The Company’s competitors within the home infusion market include Optum Infusion Pharmacy (a unit of UnitedHealth Group), Coram CVS/specialty infusion services (a division of CVS Health), Amerita Specialty Pharmacy (a division of BrightSpring Health), KabaFusion, Soleo Health, Vital Care and many other regional and local home infusion companies, ambulatory infusion centers, or specialty pharmacies including Accredo, CVS Caremark, Optum Rx, and Orsini.” 10-K for 2025
Who names Option Care Health
Companies whose own annual reports name Option Care Health as a competitor.
Word for word“In our infusion and specialty pharmacy services, we compete in the large and fragmented home infusion and specialty pharmacy markets including Option Care Health, Inc., Coram CVS/specialty infusion services (a division of CVS Health), Accredo Health Group, Inc. (a unit of Cigna), Optum Specialty Pharmacy (a subsidiary of OptumRx, which is a unit of the UnitedHealth Group), and various regional and local providers.” 10-K for 2025
Read from Option Care Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-24. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.